Thorough evaluation of the global expression of all regulators demonstrated that erasers (FTO and ALKBH5) are highly expressed in RCC compared to writers (METTL3/14, WTAP and VIRMA), specifically in ccRCC, prompting further investigation in an independent patient (IPO Porto) cohort. The gene discussed is FTO; the disease is renal cell carcinoma.